The purpose of this study is to assess the ability of the Fluids Monitor to detect hemispheric bioimpedance asymmetry associated with acute brain pathology in patients presenting with suspected Acute Ischemic Stroke (AIS).
A prospective non-significant-risk (NSR) multi-site observational study. This study will examine up to 318 subjects undergoing evaluation for acute brain pathology who directly arrive at, or are transferred to, the participating sites.
- Ischemic Stroke
- Stroke, Acute
- Cerebral Stroke
- Cerebral Infarction
- Intracerebral Hemorrhage
- Subarachnoid Hemorrhage
- Cerebral Hemorrhage
- Clot (Blood); Brain
- Intracerebral Injury
- VIPS Monitoring Diagnostic Test
Other Names: CMS Intervention Desc: Bioimpedance asymmetry ARM 1: Kind: Experimental Label: VIPS monitoring group Description: The study population will consist of adult patients presenting for evaluation of acute brain pathology,
Males and females, aged 18 years or older, who are undergoing evaluation for acute ischemic stroke
|Type||Measure||Time Frame||Safety Issue|
|Primary||Hemispheric bioimpedance asymmetry detection||At the time of VIPS monitoring - day 0|